trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Biliary Tract Neoplasms D001661 7 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Asthma D001249 52 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Alzheimer Disease D000544 76 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Adenocarcinoma, Papillary D000231 2 associated lipids
Adenocarcinoma D000230 166 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Viñuelas J et al. Towards experimental manipulation of stochasticity in gene expression. 2012 Prog. Biophys. Mol. Biol. pmid:22609563
Zhao ZN et al. TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC. 2012 PLoS ONE pmid:23028803
Tomosugi M et al. Retinoblastoma gene-independent G1 phase arrest by flavone, phosphatidylinositol 3-kinase inhibitor, and histone deacetylase inhibitor. 2012 Cancer Sci. pmid:22957647
Lin KT et al. HDAC inhibitors augmented cell migration and metastasis through induction of PKCs leading to identification of low toxicity modalities for combination cancer therapy. 2012 Clin. Cancer Res. pmid:22811583
Fleiss B et al. Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury. 2012 J Neuroinflammation pmid:22512781
Yang PM et al. CD1d induction in solid tumor cells by histone deacetylase inhibitors through inhibition of HDAC1/2 and activation of Sp1. 2012 Epigenetics pmid:22419072
Wang C et al. Genotoxic stress and activation of novel DNA repair enzymes in human endothelial cells and in the retinas and kidneys of streptozotocin diabetic rats. 2012 Diabetes Metab. Res. Rev. pmid:22228707
Mostovich LA et al. Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors. 2011 Sep-Oct Cell Adh Migr pmid:21975548
Stepanek I et al. Effects of 5-azacytidine and trichostatin A on dendritic cell maturation. 2011 Oct-Dec J. Biol. Regul. Homeost. Agents pmid:22217985
Kee HJ et al. Trichostatin A prevents neointimal hyperplasia via activation of Krüppel like factor 4. 2011 Nov-Dec Vascul. Pharmacol. pmid:21763782
Meng CF et al. DNA demethylation is superior to histone acetylation for reactivating cancer-associated genes in ovarian cancer cells. 2011 Nov-Dec Mol Med Rep pmid:21850374
Cowell IG et al. Histone deacetylase inhibition redistributes topoisomerase IIβ from heterochromatin to euchromatin. 2011 Jan-Feb Nucleus pmid:21647300
Arany I et al. Epigenetic modifiers exert renal toxicity through induction of p66shc. 2011 Anticancer Res. pmid:21965735
Hirata H et al. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. 2011 Int. J. Cancer pmid:20549706
Jafari S et al. Epigenetic modification does not determine the time of POU5F1 transcription activation in cloned bovine embryos. 2011 J. Assist. Reprod. Genet. pmid:22020531
Tseng AS et al. HDAC activity is required during Xenopus tail regeneration. 2011 PLoS ONE pmid:22022609
Rajak H et al. 2,5-Disubstituted-1,3,4-oxadiazoles/thiadiazole as surface recognition moiety: design and synthesis of novel hydroxamic acid based histone deacetylase inhibitors. 2011 Bioorg. Med. Chem. Lett. pmid:21875796
He HM et al. [The effects of a histone deacetylase (HDAC) inhibitor on endotoxin-induced endothelial cell injury]. 2011 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:22005560
Acun T et al. SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation. 2011 BMC Cancer pmid:21645397
Hou J et al. Structure-based optimization of click-based histone deacetylase inhibitors. 2011 Eur J Med Chem pmid:21621883
Gaub P et al. The histone acetyltransferase p300 promotes intrinsic axonal regeneration. 2011 Brain pmid:21705428
Song K et al. Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3B1, a novel epithelial-mesenchymal transition inducer in pancreatic cancer. 2011 Cancer Biol. Ther. pmid:21709440
Hauff KD et al. Mifepristone treatment results in differential regulation of glycerolipid biosynthesis in baby hamster kidney cells expressing a mifepristone-inducible ABCA1. 2011 Lipids pmid:21710238
Zhou S et al. Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. 2011 Circ. Res. pmid:21778425
Yoo YE and Ko CP Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis. 2011 Exp. Neurol. pmid:21712032
Qian Y et al. DeltaNp63, a target of DEC1 and histone deacetylase 2, modulates the efficacy of histone deacetylase inhibitors in growth suppression and keratinocyte differentiation. 2011 J. Biol. Chem. pmid:21317427
Zhang F et al. Role of HDAC3 on p53 expression and apoptosis in T cells of patients with multiple sclerosis. 2011 PLoS ONE pmid:21346816
Hizaki K et al. Epigenetic inactivation of calcium-sensing receptor in colorectal carcinogenesis. 2011 Mod. Pathol. pmid:21317879
Zhou X et al. Trichostatin differentially regulates Th1 and Th2 responses and alleviates rheumatoid arthritis in mice. 2011 J. Clin. Immunol. pmid:21305388
Meli M et al. Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3'-C-methyladenosine in leukaemia cells. 2011 Int. J. Oncol. pmid:21318222
Turovets N et al. Human parthenogenetic stem cells produce enriched populations of definitive endoderm cells after trichostatin A pretreatment. 2011 Differentiation pmid:21306817
Xiao J et al. Discovery, synthesis, and biological evaluation of novel SMN protein modulators. 2011 J. Med. Chem. pmid:21819082
Yang H et al. Enrichment of Nur77 mediated by retinoic acid receptor β leads to apoptosis of human hepatocellular carcinoma cells induced by fenretinide and histone deacetylase inhibitors. 2011 Hepatology pmid:21319187
Patel T et al. Chromatin remodeling resets the immune system to protect against autoimmune diabetes in mice. 2011 Immunol. Cell Biol. pmid:21321581
Chaurasia P et al. Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cells. 2011 Blood pmid:21355088
Furuta K et al. The CKH2/PKL chromatin remodeling factor negatively regulates cytokinin responses in Arabidopsis calli. 2011 Plant Cell Physiol. pmid:21357580
Zhang CZ et al. Trichostatin A sensitizes HBx-expressing liver cancer cells to etoposide treatment. 2011 Apoptosis pmid:21468663
Chen YT et al. Isolation of mesenchymal stem cells from human ligamentum flavum: implicating etiology of ligamentum flavum hypertrophy. 2011 Spine pmid:21343850
Lee MJ et al. Trichostatin A promotes the development of bovine somatic cell nuclear transfer embryos. 2011 J. Reprod. Dev. pmid:20834196
Amoêdo ND et al. Energy metabolism in H460 lung cancer cells: effects of histone deacetylase inhibitors. 2011 PLoS ONE pmid:21789245
Sengupta S et al. Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1. 2011 Oncogene pmid:20856196
Arzenani MK et al. Genomic DNA hypomethylation by histone deacetylase inhibition implicates DNMT1 nuclear dynamics. 2011 Mol. Cell. Biol. pmid:21791605
Costa VL et al. TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers. 2011 Epigenetics pmid:21847011
Fu S et al. Involvement of histone acetylation of Sox17 and Foxa2 promoters during mouse definitive endoderm differentiation revealed by microRNA profiling. 2011 PLoS ONE pmid:22132182
Puppin C et al. In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription. 2011 Cell Oncol (Dordr) pmid:21290209
Ishiguro K et al. Cutting edge: tubulin α functions as an adaptor in NFAT-importin β interaction. 2011 J. Immunol. pmid:21278340
Ma AN et al. Histone deacetylation directs DNA methylation in survivin gene silencing. 2011 Biochem. Biophys. Res. Commun. pmid:21130077
Pianta A et al. Nucleophosmin delocalization in thyroid tumour cells. 2011 Endocr. Pathol. pmid:21258971
Gómez MC et al. Trichostatin A modified histone covalent pattern and enhanced expression of pluripotent genes in interspecies black-footed cat cloned embryos but did not improve in vitro and in vivo viability. 2011 Cell Reprogram pmid:21718106
Whitehead L et al. Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors. 2011 Bioorg. Med. Chem. pmid:21723733